Gastrointestinal Cancers Detection Baltimore MD

DNA testing of a person's stool in Baltimore can accurately screen for more types of cancer than previously thought, a new study has found. While DNA stool testing has been successfully used for early detection of colorectal cancer, researchers at Minnesota's Mayo Clinic have found that the noninvasive screening is also good at finding other gastrointestinal cancers, such as those of the pancreas, stomach, bile ducts and esophagus.

Multi Specialty Healthcare
(410) 234-1600
1800 N Charles St
Baltimore, MD

Data Provided by:
Hampden Family Chiropractic
(443) 478-2892
3617 Falls Road
Baltimore, MD

Data Provided by:
Sajeev Kathuria, MD
(410) 328-6533
419 W Redwood St
Baltimore, MD
Business
University of Maryland Eye Associates
Specialties
Ophthalmology

Data Provided by:
Sheri Rowen, M.D. Laser Vision Correction
(410) 332-9500
301 Saint Paul Pl
Baltimore, MD

Data Provided by:
Camden-Inner Harbor Veterinary Services
(410) 404-1600
Camden Yards - Baltimore
Baltimore, MD

Data Provided by:
Marcia S Driscoll, MD
(410) 328-5823
419 W Redwood St
Baltimore, MD
Business
University of Maryland Dermatology
Specialties
Dermatology

Data Provided by:
Bernard Chang
(410) 332-9700
301 St. Paul Place
Baltimore, MD
Specialties
Cosmetic Surgery
Insurance
Medicare Accepted: No
Workmens Comp Accepted: No
Accepts Uninsured Patients: No
Emergency Care: No


Data Provided by:
Chengzhang Shi
(410) 905-7140
711 W. 40th St.
Baltimore, MD
Business
Cheng's Acupuncture & Herbs Clinic
Specialties
Acupuncture
Insurance
Insurance Plans Accepted: BlueCross BlueShield, EHP, United Health care, PhCS, EHP, Anthem, PHN, Kaiser
Workmens Comp Accepted: Yes
Accepts Uninsured Patients: Yes
Emergency Care: No

Doctor Information
Medical School: Union Peking Medical School/MITCM, 90/02
Additional Information
Languages Spoken: English,Chinese

Data Provided by:
Tom Ingegno M.S.O.M., L.Ac.
(410) 842-7784
715 Park Ave
Baltimore, MD
Business
Ancient Arts Acupuncture
Specialties
Acupuncture
Insurance
Insurance Plans Accepted: Blue Cross/ Blue ShieldCare FirstFederal Blue Cross/ Blue ShieldCignaUnited HealthcareAetnaMail Carriers
Medicare Accepted: No
Workmens Comp Accepted: No
Accepts Uninsured Patients: Yes
Emergency Care: No

Doctor Information
Medical School: NY College of Wholistic Health Education & Research, 2001
Additional Information
Member Organizations: NAJOM, NCCAOM, ASNY, Maryland Acupuncture Society.
Languages Spoken: English

Data Provided by:
DocSide Veterinary Medical Center
(410) 522-0055
1705 Bank St
Baltimore, MD

Data Provided by:
Data Provided by:

Gastrointestinal Cancers Detection

Provided By:

TUESDAY, June 2 (HealthDay News) -- DNA testing of a person's stool can accurately screen for more types of cancer than previously thought, a new study has found.

While DNA stool testing has been successfully used for early detection of colorectal cancer, researchers at Minnesota's Mayo Clinic have found that the noninvasive screening is also good at finding other gastrointestinal cancers, such as those of the pancreas, stomach, bile ducts and esophagus.

"Historically, we've approached cancer screening one organ at a time," the study's lead researcher, Dr. David Ahlquist, a Mayo Clinic gastroenterologist, said in a news release. "Stool DNA testing could shift the strategy of cancer screening to multi-organ, whole-patient testing and could also open the door to early detection of cancers above the colon, which are currently not screened." The potential could be enormous, he said.

The findings, to be presented in Chicago at the Digestive Disease Week 2009 conference, is based on a study of patients with cancers throughout the digestive tract and healthy control subjects. The test developed by Mayo Clinic researchers, which checked a patient's stool for the DNA of cells regularly shed from the surface of several types of tumors, detected 65 percent of esophageal cancers, 62 percent of pancreatic cancers, 75 percent of bile duct and gallbladder cancers and 100 percent of stomach and colorectal cancers. The test was equally successful at detecting early-stage and late-stage cancers.

One in four cancer deaths are the result of gastrointestinal cancers, the news release notes. These cancers are quite curable if detected at an early stage, but the only one widely tested for is colorectal cancer, generally through colonoscopy.

"Patients are often worried about invasive tests like colonoscopies, and yet these tests have been the key to early cancer detection and prevention," Ahlquist said. "Our research team continues to look for more patient-friendly tests with expanded value, and this new study reveals an opportunity for multi-organ, digestive cancer screening with a single noninvasive test."

He said the next step will be refining the tests to further improve accuracy, tumor-site prediction, speed, ease of use and affordability.

More information

The American Cancer Society has more about stomach cancer.

SOURCE: Mayo Clinic, news release, June 2, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com